Connect with us

Business

British regulators asked to assess AstraZeneca-Oxford COVID-19 vaccine, as new trial looks into lower dosage – ABC News

The British Government formally asks its medicines regulator to assess whether the AstraZeneca-Oxford COVID-19 vaccine should be authorised for use as the vaccine’s…

Published

on

post featured image

The British Government has formally asked its medicines regulator to assess whether a coronavirus vaccine developed by drug company AstraZeneca and Oxford University should be authorised for use.
It comes as AstraZeneca said it plans to conduct a new global clinical trial to assess the vaccine’s efficacy.
UK Health Secretary Matt Hancock said he had asked the Medicines and Healthcare Products Regulatory Agency to determine whether the vaccine “meets rigorous safety standards.”
Here’s the latest…

Click here to view the original article.